Findings show potential for new lipid-based delivery formulations as a platform technology for immunizationPhiladelphia, PA, ...

A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Shares of Prime Medicine (NASDAQ: PRME) are surging on Thursday. The move up comes as the S&P 500 and Nasdaq Composite gained ...

Immunotherapy has emerged as one of the major options for cancer treatment in the past decade. With the successful application of immune checkpoint inhibitors and the introduction of immune regulatory ...

DNA delivery using lipid nanoparticles results in severe toxicity in mice. However, we find that the incorporation of endogenous anti-inflammatory lipids into the lipid nanoparticles mitigates ...

Collaboration Revenue: There was $2.3 million of collaboration revenue for the year ended December 31, 2024, as compared to no collaboration revenue for the year ended December 31, 2023. The increase ...

ALBANY, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced expansion plans to its Glasgow, UK ...

Early research shows a one-time gene therapy has potential for addressing both the liver and lung disease that patients with ...

Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics ... technology platforms, research and clinical development plans, and preclinical data and other statements ...

Getting mRNA into the brain could allow scientists to instruct brain cells to produce therapeutic proteins that can help ...

Objective This study aimed to establish HAV and HEV infections in multiple small animals by intravenously injecting lipid nanoparticle ... (CAMS); Clinical Medicine Plus X—Young Scholars Project of ...